The research community working on CF is trying to identify small compounds that can act as CFTR modulators, by assisting the delivery of the mutated channel to the plasma membrane (namely correctors) and/or by increasing the ions transport through the plasma membrane (namely potentiators) [24]. Here, CFTR is linked to cystic fibrosis.